 Effects interferon-gamma therapy thyroid function T-lymphocyte subpopulations induction autoantibodies Treatment human leucocyte interferon IFN alpha development thyroid autoimmunity hypothyroidism certain phenomenon result contamination IFN gamma HLA class II antigen expression T-lymphocytes subjects females males mean age yr range chronic active hepatitis recombinant human IFN gamma rhIFN gamma im times/week weeks Goiter present patient history family history autoimmune diseases Serial thyroid functions serum free thyroid hormone index free TSH subsequent follow-up period yr normal patients adequate serial samples study serological lymphocyte subpopulations None patients rhIFN gamma thyroglobulin microsomal antibodies patients antinuclear smooth muscle autoantibodies rhIFN gamma treatment Treatment rhIFN gamma significant increase T-lymphocytes HLA-DR-positive T-cells equal proportions T-cells DR positive percentage HLA-DR-positive T-cells elevated discontinuation rhIFN gamma rhIFN gamma treatment decrease number granulocytes receptor-positive cells conclusion thyroid dysfunction thyroid autoimmunity patients dose rhIFN gamma induction autoantibodies